YTHDC1 and breast neoplasm: We analyzed patient survival and YTHDC1 gene expression data from The Cancer Genome Atlas (TCGA) cohorts and found that higher levels of YTHDC1 in breast tumors resulted in a significantly poorer prognosis (Figure 1A).